Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT
TO SECTION 12(b) OR 12(g) OF THE
SECURITIES
EXCHANGE ACT OF 1934
DERMA
SCIENCES,
INC.
(Exact
name of registrant as specified in its charter)
Pennsylvania
(State
of incorporation or organization)
|
23-2328753
(I.R.S.
Employer Identification No.)
|
|
|
214
Carnegie Center, Suite 300
Princeton,
New
Jersey
(Address
of principal executive offices)
|
08540
(Zip
Code)
|
If this
form relates to the registration of a class of securities pursuant to Section
12(b) of the Exchange Act and is effective pursuant to General Instruction
A.(c), please check the following box. x
If this
form relates to the registration of a class of securities pursuant to Section
12(g) of the Exchange Act and is effective pursuant to General Instruction
A.(d), please check the following box. o
Securities
Act registration statement file number to which this form
relates: N/A
Securities
to be registered pursuant to Section 12(b) of the Act:
Title
of each class
to be so registered
|
Name
of each exchange on which
each class is to be
registered
|
|
|
Common
stock, $0.01 par value per share
|
The
NASDAQ Stock Market LLC
|
Securities
to be registered pursuant to Section 12(g) of the Act:
N/A
(Title of Class)
Item
1.
|
Description
of Registrant’s Securities to be
Registered
|
A
description of the common stock, $0.01 par value per share, of Derma Sciences,
Inc., a Pennsylvania corporation (the “Registrant”) to be registered hereunder
is contained in the section entitled “Description of Securities” in the
prospectus included in the Registrant’s registration statement on Form S-1 (File
No. 333-163127) which was initially filed with the Securities and Exchange
Commission on November 16, 2009 (including any subsequent amendments thereto,
the “Registration Statement”), and is incorporated herein by reference. The
description of the common stock included in any form of prospectus subsequently
filed pursuant to Rule 424(b) of the Securities Act of 1933, as amended, shall
be deemed to be incorporated by reference into this registration statement on
Form 8-A.
Under the Instructions as to Exhibits
with respect to Form 8-A, no exhibits are required to be filed because no other
securities of the Registrant are registered on The NASDAQ Stock Market LLC and
the securities registered hereby are not being registered pursuant to Section
12(g) of the Securities Exchange Act of 1934, as amended.
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the
Registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereto duly authorized.
Date:
February 8, 2010
|
DERMA
SCIENCES, INC.
|
|
|
|
|
|
|
By:
|
John
E. Yetter |
|
|
|
John
E. Yetter, CPA |
|
|
|
Chief
Financial Officer |
|